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Abstract Sclerosing epithelioid fibrosarcoma (SEF) is a
rare neoplasm arising mostly in limbs and limb girdles, with a
high rate of recurrence and a strong tendency to metastasize.
This case study is of a 54-year-old woman with an asymp-
tomatic mass in the upper lobe of the left lung detected by
PET-CT when staging for Lynch syndrome-associated colon
carcinoma. Histology of the resected tumor showed epitheli-
oid cells arranged in nests, partly restiform within a zone of
sclerosing fibrosis. Immunohistochemistry was positive for
vimentin, epithelial membrane antigen, and S100-protein.
Eight months after lung resection, the patient was diagnosed
for basal cell carcinoma on her back. At the end of a two year
follow-up period, she developed metastases to the mediasti-
num, vertebrae, ribs, femurs, pelvic bones, kidneys, and one
lung, histologically all related to SEF. Here we report the first
case of a SEF primarily arising from the lung and discuss it in
the context of the current literature.
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Introduction
Sclerosing epithelioid fibrosarcoma (SEF) was first
described in 1995 by Meis-Kindblom [1]. Subsequently, a
number of cases have been reported in the literature
showing that these tumors arise as mostly deep-seated in
the soft tissue and mainly affect limbs, limb girdles, trunk,
head, and neck in young to middle-aged adults [1–4]. The
tumor belongs to the group of fibrosing fibrosarcomas,
together with low-grade fibromyxoid sarcoma and hyali-
nizing spindle cell tumor with giant rosettes [2–4]. SEF is
reported to have the most aggressive behavior among this
group, showing a low-grade histology but having a high
incidence of local recurrence and distant metastatic spread
[3, 5]. Characteristic pathological features of SEF that are
generally recognized comprise small to medium-sized
epithelioid cells with clear to eosinophilic cytoplasm and
small nucleoli [1, 5]. Immunohistochemistry (IHC) char-
acteristically shows positive vimentin staining; in some
cases additional positive staining includes epithelial
membrane antigen (EMA), S100-protein, or neuron-spe-
cific enolase (NSE) [1, 3]. Therapy of choice is a wide local
resection, while the role of systemic treatment remains
controversial [3].
Hereditary nonpolyposis colorectal cancer (HNPCC) or
Lynch syndrome is a heritable cancer syndrome associated
with colorectal carcinoma and other extracolonic malignant
manifestations. Interestingly, the occurrence of various
types of sarcomas has also been previously described [6].
Case Report
A 54-year-old woman presented with cramping pain in the
right lower abdomen. A colonoscopy and a biopsy revealed
an adenocarcinoma of the ileocecal valve. The patient had
a positive family history for hereditary nonpolyposis
colorectal cancer, Lynch syndrome II, and fulfilled the
Amsterdam criteria. Computed tomography of the thorax
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disclosed a small mass in the upper lobe of the left lung
(Fig. 1a, arrow), which was found to be fluorodeoxyglu-
cose (FDG)-negative in the staging PET-CT; however,
ipsilateral hilar lymph nodes were enlarged and FDG-
positive (Fig. 1b, c, arrow), while the patient was asymp-
tomatic. The colon cancer was completely removed by
hemicolectomy, the carcinoma was analyzed for micro-
satellite instability, and the KRAS and BRAF genes were
sequenced. As five microsatellite instability markers
(BAT25, BAT26, D2S123, D5S346, and D17S250) were
considered to be unstable, the tumor was thus defined as
unstable, but no mutation in the KRAS and BRAF genes
was found. As a diagnostic procedure, the pulmonary
tumor was wedge-resected and the hilar and lobar lymph
nodes were excised. Frozen section analysis revealed
inconclusive results in both specimens. However, the final
histological analysis showed a malignant epithelioid tumor;
thus, an extended resection as a double sleeve of the left
upper lobe was performed due to firmly adherent lymph
nodes to the pulmonary artery and bronchus. Lymph nodes
were removed from Nos. 5, 10, and 12, of which only
lymph nodes No. 12 were also positive for malignant epi-
thelioid tumor. Mediastinal lymph nodes were left in situ in
order not to compromise the blood supply of the bronchial
anastomosis.
The result of the final histological analysis was scle-
rosing epithelioid fibrosarcoma, staged pT1b pN1 cM0
with a FNCLCC grade 2, score 5 (3, 1, 1). The pathological
specimen displayed sclerosing fibrosis and hyalinosis,
partly with mucoid transformation of the stroma (Fig. 2a,
b). Within the zones of fibrosis, infiltrates of epithelioid
cells were detected, partly in nests and partly restiform
arranged, with round to oval nuclei. There was no histo-
logic evidence for metastatic disease of the colon carci-
noma. IHC was negative for pancytokeratin B (Fig. 2c,
arrow), thyroid transcription factor-1, calretinin, panmelan
A, synaptophysin, desmin, estrogen receptor, smooth
muscle actin, CD79A, CD20, and CD138, but positive for
EMA, faintly for CD10, and focally for progesterone
receptor as well as S100-protein. The histology of the
lymph nodes was identical to that of the primary tumor
(Fig. 3a), with the typical marker pattern for SEF: positive
for vimentin (Fig. 3b) and for EMA (Fig. 3c), but negative
for pancytokeratin (Fig. 3d). Analysis of the proteins
encoded by mismatch repair genes (MSH2, MSH6, MLH1,
and PMS2) showed positive staining (Fig. 3e, f), which
makes an association of SEF with Lynch syndrome less
likely.
Meanwhile, the patient received nine cycles of FOLFOX
chemotherapy. Eight months after surgery the patient
developed a lesion on the back which was removed and
histologically showed a multilocular superficial-type basal
cell carcinoma. A follow-up PET-CT showed positivity
within the fifth lumbar vertebra, left iliac bone, left femur,
and mediastinum, and a biopsy from mediastinal lymph
nodes and also from bone lesions confirmed metastatic
spread from the pulmonary SEF. All osseous metastases
were subsequently treated by radiotherapy with curative
intent. Accordingly, the mediastinal lymph nodes were also
resected in a curative treatment concept. In the same
operation, an unexpected lesion in the right upper lobe was
also removed, and both specimens were confirmed to be
metastases from the SEF.
A follow-up PET-CT a few months later showed further
metastatic spread to multiple bone locations as well as to
mediastinum and kidneys, while the lung remained tumor-
free. At the time of evaluation, the patient was asymp-
tomatic but underwent radiation therapy for extrapulmo-
nary metastases.
Discussion
This case of SEF is unusual for the following aspects: (1)
SEF arose primarily from the lung, (2) the patient developed
Fig. 1 a Computed tomography of the thorax of a 54-year-old female
with a round mass in the left upper lobe measuring 2.5 cm. b, c PET-
CT scan shows enlarged FDG-positive ipsilateral hilar lymph nodes
while the primary pulmonary tumor is FDG-negative
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three metachronous tumors of completely distinct histology
within a short period of time, (3) SEF and basal cell car-
cinoma were suspected to be associated with Lynch
syndrome.
SEF originating from the lung has not been described as yet
as this tumor entity arises mostly from the deep soft tissue of
limbs and limb girdles, head, neck, and trunk [3, 4]. However,
the histological appearance of SEF in our patient is in accor-
dance to the reported literature, showing dense collagenous
stroma with small to medium epithelioid cells arranged in
cords and strands, staining positive for vimentin. Surprisingly,
the primary tumor within the lung was FDG-negative, possi-
bly due to the low metabolic activity of fibrous tumors in
general [7]. Surprisingly, hilar lymph nodes were proven to be
tumor-free but showed a strong FDG signal, most likely due to
unspecific inflammation.
Hereditary nonpolyposis colorectal cancer (HNPCC) or
Lynch syndrome is an autosomal dominant multiorgan
cancer syndrome that emerges in individuals with muta-
tions in DNA mismatch repair (MMR) genes, e.g., hMLH1
or hPMS1. Loss of function of the MMR system leads to
the accumulation of DNA replication errors in the HNPCC-
associated tumors. This phenomenon is also known as
microsatellite (MS) instability [8]. The most frequent
malignancy in individuals with Lynch syndrome is colo-
rectal cancer. Among many tumor entities, fibrosarcoma,
skin cancer, and several types of lung cancer were
described in HNPCC mutation carriers or patients meeting
the Amsterdam criteria [9–11]. Lynch syndrome-associated
tumors can show a loss of immunohistochemical staining
for the protein encoded by the mutated MMR gene [8]. The
tumor in our patient showed normal staining for all four
proteins analyzed, which makes an association with the
Lynch syndrome less likely.
A possible association between tumors of the skin and
HNPCC is described with regard to Muir-Torre syndrome
[9, 12]. There is only one published case of a patient who
suffered from colorectal cancer and various skin cancers,
including basal cell carcinoma [13].
According to the literature, between 30 and 50 % of
SEF patients had local relapse between two to five years
after initial diagnosis [1, 3–5]. In contrast, except for one
metastasis in the upper right lobe, the lung of this patient
remained disease-free. Therefore, a radical local resection
treatment is justified and should be recommended for pri-
mary lung SEF.
Fig. 2 Representative histology of sclerosing epithelioid fibrosar-
coma of the primary pulmonary specimen: Hematoxylin & eosin
[H&E, magnification 9100 (a) and 9200 (b)], showing epithelioid
cells, arranged in a restiform manner or in nests, and embedded in a
fibrotic matrix. Immunohistochemistry was negative for pancytoker-
atin within the tumor (c, arrow), while normal lung tissue showed
extensive pancytokeratin staining (dashed arrow)
Lung (2012) 190:691–695 693
123
Conflict of interest The authors have no conflicts of interest or
financial ties to disclose.
References
1. Meis-Kindblom JM, Kindblom LG, Enzinger FM (1995) Scle-
rosing epithelioid fibrosarcoma. A variant of fibrosarcoma sim-
ulating carcinoma. Am J Surg Pathol 19(9):979–993
2. Smith PJ, Almeida B, Krajacevic J, Taylor B (2008) Sclerosing
epithelioid fibrosarcoma as a rare cause of ascites in a young
man: a case report. J Med Case Rep 2:248
3. Ossendorf C, Studer GM, Bode B, Fuchs B (2008) Sclerosing
epithelioid fibrosarcoma: case presentation and a systematic
review. Clin Orthop Relat Res 466(6):1485–1491
4. Hansen T, Katenkamp K, Brodhun M, Katenkamp D (2006) Low-
grade fibrosarcoma—report on 39 not otherwise specified cases
and comparison with defined low-grade fibrosarcoma types.
Histopathology 49(2):152–160
Fig. 3 Histology and immunohistochemistry from metastatic lymph
nodes. Hematoxylin & eosin (H&E) shows extensive fibrotic tissue
with scarce remaining normal lymph node architecture (a). Vimentin
was strongly positive (b) and there were considerable amounts of
epithelial membrane antigen (EMA) expressed (c), while pancyto-
keratin was absent (d) (magnification 9100). All cells showed an
equal distribution of normal nuclear staining for MLH1 (e) and MSH2
(f)
694 Lung (2012) 190:691–695
123
5. Tsuchido K, Yamada M, Satou T, Otsuki Y, Shimizu S, Ko-
bayashi H (2010) Cytology of sclerosing epithelioid fibrosarcoma
in pleural effusion. Diagn Cytopathol 38(10):748–753
6. Nilbert M, Therkildsen C, Nissen A, Akerman M, Bernstein I
(2009) Sarcomas associated with hereditary nonpolyposis colo-
rectal cancer: broad anatomical and morphological spectrum.
Fam Cancer 8(3):209–213
7. Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, Im JG
(2006) False positive and false negative FDG-PET scans in var-
ious thoracic diseases. Korean J Radiol 7(1):57–69
8. Yu VP, Novelli M, Payne SJ, Fisher S, Barnetson RA, Frayling
IM, Barrett A, Goudie D, Ardern-Jones A, Eeles R, Shanley S
(2009) Unusual presentation of Lynch syndrome. Hered Cancer
Clin Pract 7(1):12
9. Koornstra JJ, Mourits MJ, Sijmons RH, Leliveld AM, Hollema H,
Kleibeuker JH (2009) Management of extracolonic tumours in
patients with Lynch syndrome. Lancet Oncol 10(4):400–408
10. Heinimann K, Mu¨ller H, Weber W, Scott RJ (1997) Disease
expression in Swiss hereditary non-polyposis colorectal cancer
(HNPCC) kindreds. Int J Cancer 74(3):281–285
11. Peltoma¨ki P, Gao X, Mecklin JP (2001) Genotype and phenotype
in hereditary nonpolyposis colon cancer: a study of families with
different vs. shared predisposing mutations. Fam Cancer 1(1):
9–15
12. Nolan L, Eccles D, Cross E, Crawford G, Beck N, Bateman A,
Ottensmeier C (2009) First case report of Muir-Torre syndrome
associated with non-small cell lung cancer. Fam Cancer 8(4):
359–362
13. Ang JM, Alai NN, Ritter KR, Machtinger LA (2011) Muir-Torre
syndrome: case report and review of the literature. Cutis 87(3):
125–128
Lung (2012) 190:691–695 695
123
